In a steady-state GTPase activity assay, N- [3-(1H-imidazol-4-yl)propyl)]guanidines and N G -acylated derivatives are more potent and efficacious at fusion proteins of guinea pig (gpH 2 R-G s␣S ) than human (hH 2 R-G s␣S ) histamine H 2 receptor, coupled to the short splice variant of G s␣ , G s␣S . Whereas Ala-271 (hH 2 R) and Asp-271 (gpH 2 R) in transmembrane domain 7 were identified to determine the potency differences of guanidine-type agonists, the molecular basis for the efficacy differences remains to be elucidated. A homology model of the gpH 2 R suggested that an H-bond between Tyr-17 and Asp-271 stabilizes an active receptor conformation of the gpH 2 R. In the present study, we generated a mutant hH 2 R-G s␣S with Cys-173 Tyr-17/Ala-2713 Asp-271 exchanges (hH 2 R3gpH 2 R) that exhibited an enhanced level of constitutive GTPase activity and adenylyl cyclase activity compared with wild-type hH 2 R-G s␣S and gpH 2 R-G s␣S . Potencies and efficacies of guanidines and N G -acylguanidines were increased at this mutant receptor compared with hH 2 R-G s␣S , but they were still lower than at gpH 2 R-G s␣S , suggesting that aside from Tyr-17 and Asp-271 additional amino acids contribute to the distinct pharmacological profiles of both species isoforms. Another hH 2 R-G s␣S mutant with a Cys-173 Tyr-17 exchange showed inefficient coupling to G s␣S as revealed by reduced agonist-stimulated GTPase and basal adenylyl cyclase activities. Collectively, our present pharmacological study confirms the existence of an H-bond between Tyr-17 and Asp-271 favoring the stabilization of an active receptor conformation. Distinct potencies and efficacies of agonists and inverse agonists further support the concept of ligand-specific conformations in wild-type and mutant H 2 R-G s␣S fusion proteins.
H 2 R of human neutrophils than at the H 2 R of the guinea pig right atrium (Burde et al., 1989 (Burde et al., , 1990 . In a membrane steady-state GTPase activity assay with fusion proteins of H 2 R and the short splice variant of G s␣ , G s␣S , these compounds are considerably more potent and efficacious at gpH 2 R-G s␣S than at hH 2 R-G s␣S (Kelley et al., 2001) . Recently, a novel class of N G -acylated imidazolylpropylguanidines was developed (Ghorai, 2005) . The introduction of an electron-withdrawing carbonyl group adjacent to the guanidine moiety reduces the basicity of the compounds (pK a of ϳ8). This structural modification does not change the species selectivity between hH 2 R-G s␣S and gpH 2 R-G s␣S (Xie et al., 2006a) . By contrast, HA and the small H 2 R agonists dimaprit (DIM; Fig. 1 , 2) and amthamine (AMT; Fig. 1, 3) do not exhibit species selectivity.
A three-dimensional homology model of the gpH 2 R suggested that the nonconserved Asp-271 in transmembrane domain (TM) 7 confers high potency to the guanidines, which was subsequently confirmed by an Ala-2713 Asp-271 mutation in hH 2 R-G s␣S (hH 2 R-A271D-G s␣S ) (Kelley et al., 2001) . However, the efficacies of guanidines at this mutant and at hH 2 R/gpH 2 R chimeras were lower than at gpH 2 R, demonstrating that guanidine efficacy depends on additional or other interactions. As a rationale, an interhelical H-bond between Tyr-17 in TM1 and Asp-271 was predicted from the model, stabilizing an active guanidine-bound conformation only in gpH 2 R but not in hH 2 R (containing Cys-17 and Ala-271) (Kelley et al., 2001 ).
To test this hypothesis, we generated an hH 2 R-G s␣S mutant with a Cys-173 Tyr-17 exchange and a double mutant with Cys-173 Tyr-17 and Ala-2713 Asp-271 exchanges in the sequence of hH 2 R. Sf9 cell membranes expressing mutant and wild-type H 2 R-G s␣S were used to measure steady-state GTPase activity, because this system was previously shown to be reliable and very sensitive to analyze ligand potencies and efficacies (Seifert et al., 1999; Milligan, 2000) . due to the defined 1:1 stoichiometry of receptor and G s␣ in fusion proteins, ligand potencies and efficacies in the steady-state GTPase assay are independent of the expression levels, allowing for the comparison of various membrane preparations with different expression levels. We also assessed AC activity in Sf9 membranes as a sensitive readout to compare distinct levels of constitutive activity of mutant and wild-type H 2 R-G s␣S fusion proteins. Figure 1 shows the structures of H 2 R agonists examined in the present study. Impromidine (IMP; 5), arpromidine (ARP; 6), and BU-E-43 (7) are representatives of N- [3-(1H-imidazol-4-yl) propyl]guanidines. Their N G -acylated derivatives contain diverse diarylpropanoyl (9 and 11), 3-(hetero)arylbutanoyl (8 and 10), and 3-(cyclohexylbutanoyl) (12) groups. Compound 13 contains a 2-amino-4-methylthiazol-5-yl group and exhibits enhanced selectivity relative to the H 3 R (Ghorai, 2005) . Compounds 10 and 13 are the pure (R)-enantiomers. In addition, the inverse agonists cimetidine (CIM; 14), ranitidine (RAN; 15), famotidine (FAM; 16), aminopotentidine (APT; 17), and iodoaminopotentidine (IAPT; 18) were studied (Hill et al., 1997; Dove et al., 2004) . Structures of H 2 R agonists and inverse agonists. 1 to 3, small H 2 R agonists; 4, H 1 R agonist with partial agonism at the H 2 R; 5 to 7, guanidine-type H 2 R agonists; 8 to 12, N G -acylated N- [3-(1H-imidazol-4-yl) propyl]guanidines with agonistic H 2 R activity; 13, (R)-N-[3-(2-amino-4-methylthiazol-5-yl)propyl]-NЈ-(3-phenylbutanoyl)guanidine, an H 2 R agonist; and 14 to 18, H 2 R inverse agonists.
Materials and Methods
Materials. The generation of pGEM-3Z-SF-hH 2 R-G s␣S , pGEM-3Z-SF-hH 2 R-A271D-G s␣S , and pVL1392-SF-hH 2 R-G s␣S was described previously (Kelley et al., 2001) . The generation of the baculoviruses encoding hH 2 R-G s␣S and gpH 2 R-G s␣S was described previously (Kelley et al., 2001; Houston et al., 2002) . Compounds 8 and 11 and 13 (Ghorai, 2005; Xie et al., 2006a) and compound 12 (Xie et al., 2006b) were prepared as described. IMP was synthesized as described previously (Durant et al., 1978) . ARP and BU-E-43 were synthesized as described previously (Buschauer, 1989) . APT and IAPT were prepared as described previously (Hirschfeld et al., 1992) . Suprahistaprodifen was synthesized as described previously (Elz et al., 2000) . The structures of compounds were confirmed by elemental analysis (C, H, N) , 1 H NMR, and mass spectrometry. Purity of compounds was Ͼ98% as determined by high-performance liquid chromatography or capillary electrophoresis. The anti-FLAG Ig (M1 monoclonal antibody) was from Sigma-Aldrich (St. Louis, MO), and the anti-His 6 Ig was from Clontech (Mountain View, CA). [␥-32 P]GTP was synthesized through phosphorylation of GDP by enzymatic conversion of L-␣-glycerol phosphate to 3-phosphoglycerate following a procedure described previously (Walseth and Johnson, 1979 Construction of the cDNA for hH 2 R-C17Y-G s␣S . The Cys-173 Tyr-17 exchange in hH 2 R was generated by sequential overlapextension PCRs. With pGEM-3Z-SF-hH 2 R-G s␣S as template, PCR 1A was used to amplify a DNA fragment consisting of the cleavable signal peptide from influenza hemagglutinin (S), the FLAG epitope (F) recognized by the M1 monoclonal antibody, and the N-terminal portion of the hH 2 R. The sense primer annealed with 18 base pairs of pGEM-3Z before the 5Ј end of SF. The antisense primer encoded the sequence 5Ј-GATCTTATATGCGGTAGAGTCTAGACAAAAGG-AAGAGGCTG-3Ј to generate the Cys-173 Tyr-17 exchange and a new XbaI site (TCTAGA). In PCR 1B, the DNA sequence of the hH 2 R, a hexahistidine tag, and the entire sequence of G s␣S was amplified using pGEM-3Z-SF-hH 2 R-G s␣S as template. The sense primer encoded the sequence Ј-CTTTTGTCTAGACTCTACCGCAT-ATAAGATCACCATCACCG-3Ј to generate the Cys-173 Tyr-17 exchange and the new XbaI site. The antisense primer annealed with the cDNA encoding the five C-terminal amino acids of G s␣S , the stop codon, and an XbaI site. In PCR 2, the products of PCR 1A and 1B annealed in the region encoding the newly created Cys-173 Tyr-17 exchange and the new XbaI site. Here, the sense primer of PCR 1A and the antisense primer of PCR 1B were used. In that way, the complete cDNA for the hH 2 R-C17Y-G s␣S fusion protein was amplified. The product of PCR 2 was digested with SacI and KpnI and cloned into pGEM-3Z-SF-hH 2 R-G s␣S digested with SacI and KpnI. pGEM-3Z-SF-hH 2 R-C17Y-G s␣S was digested with SacI and EcoN I and cloned into the baculovirus transfer vector pVL1392-SFhH 2 R-G s␣S digested with SacI and EcoNI. PCR-generated DNA sequences were confirmed by extensive restriction enzyme analysis and enzymatic sequencing.
Construction of the cDNA for hH 2 R-C17Y-A271D-G s␣S . To generate the DNA for fusion proteins with two amino acid exchanges Cys-173 Tyr-17 and Ala-2713 Asp-271, pGEM-3Z-SF-hH 2 R-A271D-G s␣S was digested with KpnI and BglII and cloned into pGEM-3Z-SF-hH 2 R-C17Y-G s␣S digested with KpnI and BglII. pGEM-3Z-SFhH 2 R-C17Y-A271D-G s␣S was digested with NcoI and BglII and cloned into the baculovirus transfer vector pVL1392-SF-hH 2 R-G s␣S digested with NcoI and BglII.
Generation of Recombinant Baculoviruses, Cell Culture, and Membrane Preparation. Recombinant baculoviruses encoding hH 2 R-C17Y-G s␣S and hH 2 R-C17Y-A271D-G s␣S were generated in Sf9 cells using the BaculoGOLD transfection kit (BD Biosciences PharMingen, San Diego, CA) according to the manufacturer's instructions. After initial transfection, high-titer virus stocks were generated by two sequential virus amplifications. Sf9 cells were cultured in 250-ml disposable Erlenmeyer flasks at 28°C under rotation at 125 rpm in SF 900 II medium (Invitrogen, Carlsbad, CA) supplemented with 5% (v/v) fetal calf serum (Cambrex Bio Science Walkersville Inc., Walkersville, MD) and 0.1 mg/ml gentamicin (Cambrex Bio Science Walkersville Inc.). Cells were maintained at a density of 0.5 to 6.0 ϫ 10 6 cells/ml. For infection, cells were sedimented by centrifugation and suspended in fresh medium. Cells were seeded at 3.0 ϫ 10 6 cells/ml and infected with a 1:100 dilution of high-titer baculovirus stocks encoding H 2 R-G s␣S fusion proteins. Cells were cultured for 48 h before membrane preparation. Sf9 membranes were prepared as described previously (Seifert et al., 1998a) , using 1 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, 10 g/ml benzamidine, and 10 g/ml leupeptin as protease inhibitors. Membranes were suspended in binding buffer (12.5 mM MgCl 2 , 1 mM EDTA, and 75 mM Tris-HCl, pH 7.4) and stored at Ϫ80°C until use.
SDS-PAGE and Immunoblot Analysis. Membrane proteins were separated on SDS polyacrylamide gels containing 12% (w/v) acrylamide. Proteins were transferred onto Immobilon-P membranes (Millipore Corporation, Bedford, MA) and reacted with M1 antibody, or anti-His 6 Ig (1:1000 each). Protein bands were visualized by enhanced chemoluminescence (Pierce Chemical, Rockford, IL) using sheep anti-mouse IgG, coupled to peroxidase.
Steady-State GTPase Activity Assay. Membranes were thawed, sedimented, and resuspended in 10 mM Tris-HCl, pH 7.4. Assay tubes contained Sf9 membranes expressing H 2 R-G s␣S fusion proteins (10 g of protein/tube), 1.0 mM MgCl 2 , 0.1 mM EDTA, 0.1 mM ATP, 100 nM GTP, 0.1 mM adenylyl imidodiphosphate, 5 mM creatine phosphate, 40 g of creatine kinase, and 0.2% (w/v) bovine serum albumin in 50 mM Tris-HCl, pH 7.4, and H 2 R ligands at various concentrations. Reaction mixtures (80 l) were incubated for 2 min at 25°C before the addition of 20 l of [␥-32 P]GTP (0.1 Ci/ tube). All stock and work dilutions of [␥- 32 P]GTP were prepared in 20 mM Tris-HCl, pH 7.4. Reactions were conducted for 20 min at 25°C. Preliminary studies under basal conditions and with HA, IMP, and ARP showed that under these conditions, GTP hydrolysis was linear. Reactions were terminated by the addition of 900 l of slurry consisting of 5% (w/v) activated charcoal and 50 mM NaH 2 PO 4 , pH 2.0. Charcoal absorbs nucleotides but not P i . Charcoal-quenched reaction mixtures were centrifuged for 7 min at room temperature at 15,000g. Six hundred microliters of the supernatant fluid of reaction mixtures was removed, and 32 P i was determined by liquid scintillation counting. Enzyme activities were corrected for spontaneous degradation of [␥- 32 P]GTP. Spontaneous [␥-32 P]GTP degradation was determined in tubes containing all of the above-described components plus a very high concentration of unlabeled GTP (1 mM) that, by competition with [␥- 32 P]GTP, prevents [␥-32 P]GTP hydrolysis by enzymatic activities present in Sf9 membranes. Spontaneous [␥- 32 P]GTP degradation was Ͻ1% of the total amount of radioactivity added using 20 mM Tris-HCl, pH 7.4, as solvent for [␥- 32 P]GTP. The experimental conditions chosen ensured that not more than 10% of the total amount of [␥- 32 P]GTP added was converted to 32 P i . AC Activity Assay. AC activity in Sf9 membranes was determined as described previously (Houston et al., 2002) . In brief, membranes were thawed and sedimented by a 15-min centrifugation at 4°C and 15,000g to remove residual endogenous guanine nucleotides as far as possible, and they were subsequently resuspended in binding buffer. Tubes contained Sf9 membranes expressing H 2 R-G s␣S Miscellaneous. Protein concentrations were determined using the DC protein assay kit (Bio-Rad, Hercules, CA). [
3 H]Dihydroalprenolol saturation binding was performed as described previously (Seifert et al., 1998a) . All analyses of experimental data were performed with the Prism 4 program (GraphPad Software Inc., San Diego, CA). K B values were calculated using the Cheng and Prusoff (1973) equation. Expression levels of recombinant proteins were determined using the GS-710 calibrated imaging densitometer and the software tool Quantity One version 4.0.3 (Bio-Rad).
Results

Immunological Detection of Recombinant Proteins in Sf9 Cell
Membranes. In Sf9 cells hH 2 R-C17Y-G s␣S and hH 2 R-C17Y-A271D-G s␣S were well expressed (Fig. 2, A and B). Monomeric nonfused H 2 R expressed in Sf9 cells migrates as an ϳ33-kDa band in SDS-PAGE (Fukushima et al., 1997; Houston et al., 2002) , and the apparent molecular mass of G s␣S is ϳ45 kDa (Graziano et al., 1989) . SDS-PAGE analysis of membranes expressing hH 2 R-C17Y-A271D-G s␣S yielded intense bands at ϳ80 kDa, recognized by both the anti-FLAG and the anti-His 6 antibodies, that coincide with the expected apparent molecular masses of H 2 R-G s␣S monomers (Kelley et al., 2001; Houston et al., 2002) . Both bands seemed somewhat diffuse, representing different glycosylation forms of the proteins. With the anti-His 6 antibody, an additional doublet band was detected at ϳ45 kDa not recognized by the anti-FLAG antibody, which is presumably due to a lack of epitope exposure. By contrast, SDS-PAGE of membranes expressing hH 2 R-C17Y-G s␣S yielded strong and diffuse bands at ϳ40 kDa and lacked the expected bands at ϳ80 kDa. These bands could either represent atypically migrating glycosylated forms of H 2 R-G s␣S monomers or degraded proteins. Because the anti-FLAG Ig recognizes the N terminus and the anti-His 6 Ig the C terminus of the H 2 R, it can be concluded that for either case the complete amino acid sequence of hH 2 R-C17Y was expressed. Additional diffuse bands at ϳ110 kDa may correspond to GPCR dimers or higher oligomers and were also observed in wild-type hH 2 R-G s␣S fusion proteins (Kelley et al., 2001) . Comparison with the peak intensities of calibrated Sf9 membranes expressing the ␤ 2 -adrenergic receptor (AR) at 7.5 pmol mg Ϫ1 (as determined by [ 3 H]dihydroalprenolol saturation binding) revealed approximately similar expression levels of ϳ2 pmol mg Ϫ1 for hH 2 R-C17Y-G s␣S and hH 2 R-C17Y-A271D-G s␣S .
Agonist and Inverse Agonist Effects on GTPase Activities in Sf9 Membranes Expressing hH 2 R-G s␣S , gpH 2 R-G s␣S , hH 2 R-C17Y-G s␣S , and hH 2 R-C17Y-A271D-G s␣S . The basal GTPase activity of hH 2 R-G s␣S amounted to 0.66 Ϯ 0.09 pmol mg Ϫ1 min Ϫ1 (n ϭ 10). Compared with it, the data were similar in membranes expressing gpH 2 R-G s␣S (0.69 Ϯ 0.19 pmol mg Ϫ1 min Ϫ1 ; n ϭ 8; p Ͼ 0.05) and hH 2 R-C17Y-G s␣S (0.78 Ϯ 0.10 pmol mg Ϫ1 min Ϫ1 ; n ϭ 9; p Ͼ 0.05), respectively, but significantly increased at hH 2 R-C17Y-A271D-G s␣S (1.67 Ϯ 0.38 pmol mg Ϫ1 min Ϫ1 ; n ϭ 9; p Ͻ 0.01). At the fusion proteins of both wild-type receptors and at hH 2 R-C17Y-A271D-G s␣S , stimulation with 100 M HA yielded GTPase activities 400 to 600% of the basal levels. By contrast, at hH 2 R-C17Y-G s␣S , maximal HA GTPase activities amounted to just 140% of the basal signal, thereby providing an insufficiently low signal-to-noise ratio for detailed analysis of agonists (Fig. 3) . Thus, for a comparative analysis of efficacies and potencies of compounds 1 to 13, only membranes expressing both wild-type receptors and the double mutant hH 2 R-C17Y-A271D-G s␣S were considered (Table 1) . The efficacies of the small agonists DIM (2) and AMT (3) were slightly increased at gpH 2 R-G s␣S and hH 2 R-C17Y-A271D-G s␣S , relative to hH 2 R-G s␣S . The potencies of HA (1) (Fig. 3) , DIM (2), and AMT (3) were increased at hH 2 R-C17Y-A271D-G s␣S compared with the wild-type receptors. The H 1 R-selective agonist suprahistaprodifen (4) acted as a partial agonist with similar efficacies and potencies at hH 2 R-G s␣S , gpH 2 R-G s␣S , and hH 2 R-C17Y-A271D-G s␣S . In agreement with previous studies (Kelley et al., 2001; Xie et al., 2006a,b), N-[3-(1H-imidazol-4-yl) propyl]guanidines 5 to 7 and most of their N G -acylated derivatives 8 to 13 were more efficacious and more potent at gpH 2 R-G s␣S than at hH 2 R-G s␣S . Except for IMP (5) being more efficacious at hH 2 R-C17Y-A271D-G s␣S , the efficacies of 5 to 7 were not significantly changed at the mutant receptor compared with wild-type hH 2 R-G s␣S . Compound 11 but not ARP (6) was more efficacious and both were more potent at hH 2 R-C17Y-A271D-G s␣S than at wild-type hH 2 R-G s␣S . Compounds 8 and 9 share a 2-thiazolyl moiety and were more potent at the double mutant compared with hH 2 R-G s␣S , although for compound 9 the difference was not significant. When the 2-thiazolyl group was replaced by a cyclohexyl group (12), the selectivity for the mutant was lost. Taken together, the small H 2 R agonists 1 to 3 were considerably more potent at hH 2 R-C17Y-A271D-G s␣S than at the wild-type human and guinea pig H 2 R-G s␣S . Some guanidines and N G -acylated guanidines displayed enhanced potencies at the mutant receptor compared with hH 2 R-G s␣S . However, these compounds were all less potent at hH 2 R-C17Y-A271D-G s␣S than at gpH 2 R-G s␣S , and the efficacies varied between the corresponding values at both wild-type receptors.
At wild-type H 2 R-G s␣S and hH 2 R-C17Y-A271D-G s␣S CIM (14), RAN (15), FAM (16), APT (17), and IAPT (18) decreased GTPase activities below basal and thus acted as inverse agonists (Table 2) . At hH 2 R-C17Y-A271D-G s␣S inverse agonist efficacies of 14 to 18 were significantly increased relative to wild-type receptors. Because inverse agonists stabilize an inactive receptor conformation (Milligan et al., 1995) , the differences in inverse agonist efficacies reflect an increased level of constitutive activity of hH 2 R-C17Y-A271D-G s␣S relative to wild-type receptors. The magnitudes of constitutive activity measured critically depend on the relative stoichiometry of GPCR and G protein in the system (Kenakin, 2001) . Physical tethering of H 2 R with G s␣S in the fusion proteins used provides a fixed 1:1 stoichiometry of both partners, allowing for a direct comparison of the efficacies in an expression-independent manner (Milligan, 2000) . Compounds 16 and 18 were slightly more potent at hH 2 R-C17Y-A271D-G s␣S than at the wild-type receptors, whereas no significant differences in the K B values were observed for 14, 15, and 17.
Regulation of AC Activities in Membranes Expressing hH 2 R-G s␣S , gpH 2 R-G s␣S , hH 2 R-C17Y-G s␣S , and hH 2 R-C17Y-A271D-G s␣S . AC activities were measured in Sf9 membranes expressing hH 2 R-C17Y-G s␣S and hH 2 R-C17Y-A271D-G s␣S , and they were compared with results at wild-type human and guinea pig H 2 R-G s␣S (Table 3) . hH 2 R-G s␣S and gpH 2 R-G s␣S were similarly expressed in Sf9 cells (at ϳ3 and 1 pmol mg Ϫ1 , respectively) and produced similar basal AC activities. By contrast, basal AC activities were increased ϳ3-fold at hH 2 R-C17Y-A271D-G s␣S . At both mutant and both wild-type receptors, 10 M GTP by itself increased AC activities above the basal level (Fig. 4) , indicating constitutive activity of these receptors (Seifert et al., 1998a,b; Gille and Seifert, 2003) . Accordingly, at all four H 2 Rs, the inverse agonist IAPT (18) reduced this GTP-dependent AC activity. At hH 2 R-G s␣S and gpH 2 R-G s␣S , AC activity increases by 10 M GTP achieved 73 and 77%, respectively, of the signal increases by 10 M GTP plus 100 M HA. Strikingly, at hH 2 R-C17Y-A271D-G s␣S , HA did not further enhance the GTP effect. Both higher basal AC activity and a strong stimulation by GTP caused exhaustion of the limiting Fig. 3 . Concentration-dependent increase of GTPase activity by HA in membranes expressing hH 2 R-G s␣S (f), gpH 2 R-G s␣S (), hH 2 R-C17Y-G s␣S (F), and hH 2 R-C17Y-A271D-G s␣S (OE). GTPase activity in Sf9 membranes was determined as described under Materials and Methods. Reaction mixtures contained membranes (10 g of protein/tube) expressing fusion proteins and HA at concentrations indicated on the abscissa. Data shown are the means Ϯ S.E.M. of three independent experiments performed in duplicates. Data were analyzed by nonlinear regression and were best fitted to sigmoidal concentration-response curves.
TABLE 1
Agonist efficacies and potencies at hH 2 R-G s␣S , gpH 2 R-G s␣S , and hH 2 R-C17Y-A271D-G s␣S in the GTPase assay Steady-state GTPase activity in Sf9 membranes expressing hH 2 R-G s␣S , gpH 2 R-G s␣S , and hH 2 R-C17Y-A271D-G s␣S was determined as described under Materials and Methods. Reaction mixtures contained Sf9 membranes expressing fusion proteins and agonists at concentrations from 1 nM to 1 mM as appropriate to generate saturated concentration-response curves. Curves were analyzed by nonlinear regression and were best fitted to sigmoidal concentration-response curves. The maximal stimulatory effect of 100 M HA amounted to 400 to 600% above basal. To calculate agonist efficacies, the maximum stimulatory effect of HA was set at 1.00, and the stimulatory effects of other agonists were referred to this value. Data shown are the means Ϯ S.D. of three to six experiments performed in duplicate or triplicate. Efficacies and potencies, respectively, of ligands at hH 2 R-G s␣S were compared with the corresponding parameters at gpH 2 R-G s␣S , and hH 2 R-C17Y-A271D-G s␣S , respectively, using the t test. The control data for hH 2 R-G s␣S and gpH 2 R-G s␣S are identical with the control data for these constructs in Table 1 of Preuss et al. (2007 pool of AC molecules in Sf9 cells and reflect an increased level of constitutive activity of hH 2 R-C17Y-A271D-G s␣S , compared with the wild-type fusion proteins. Similar reduced agonistresponsiveness due to high constitutive activity was shown for other aminergic GPCRs, e.g., ␤ 2 AR-G s␣ fusion proteins (Seifert et al., 1998a) and mutants of the 5-HT 4 receptor (Claeysen et al., 1999) . At hH 2 R-C17Y-G s␣S much lower basal AC activities and a much smaller stimulatory effect of GTP were determined. In this case, GTP on its own caused only 26% of the effect with HA addition. At hH 2 R-G s␣S , gpH 2 R-G s␣S , and hH 2 R-C17Y-A271D-G s␣S , 100 M HA reduced the basal AC activities in the absence of added GTP (Fig. 4, A-C) . Similar effects were observed at ␤ 2 AR-G s␣S fusion proteins (Seifert et al., 1998b) , and they are due to dissociation of GDP from G s␣S following agonist binding to the receptor without subsequent binding of GTP. G s␣-GDP is more effective in activating AC than nucleotide-free G s␣ ; therefore, AC activities were decreased.
Discussion
Impaired Coupling in Membranes Expressing hH 2 R-C17Y-G s␣S . In Sf9 cells expressing hH 2 R-C17Y-G s␣S , the anti-FLAG and the anti-His 6 antibodies recognized similarly migrating proteins in SDS-PAGE that did not coincide with the expected bands for monomeric H 2 R-G s␣S fusion proteins. Measurement of GTP hydrolysis at hH 2 R-C17Y-G s␣S yielded HA responses, but the increases in GTPase activity upon agonist stimulation were much lower than in the wild-type H 2 R-G s␣S species isoforms. Moreover, with this receptor mutant, substantial stimulatory effects of HA and inhibitory effects of IAPT on the GTP-dependent AC activity increases were observed, but the basal AC activities and the stimulatory effects of GTP were largely reduced relative to wild-type H 2 R-G s␣S species isoforms, and they were similar to the values typical for Sf9 membranes expressing nonfused H 2 R species (Houston et al., 2002) . These controversial results of hH 2 R-C17Y-G s␣S relative to hH 2 R-G s␣S and gpH 2 R-G s␣S imply the following conclusions: The proteins expressed in Sf9 cells made up the amino acid sequence for hH 2 R-C17Y, and they were functional in the test systems used. However, coupling of hH 2 R-C17Y to G s␣S was much less efficient than is characteristic for GPCR-G s␣ fusion proteins (Seifert et al., 1999; Gille and Seifert, 2003) . As a rationale, G s␣S could be incorrectly expressed or degraded in Sf9 cells. Instead, hH 2 R-C17Y possibly coupled to only a fraction of recombinant G s␣S or to endogenous G s␣ -like G proteins with much lower efficiency.
Increased Constitutive Activity in Membranes Expressing hH 2 R-C17Y-A271D-G s␣S . In membranes expressing hH 2 R-C17Y-A271D-G s␣S , high-efficiency coupling was observed as GTPase activities were increased upon agonist stimulation similar to hH 2 R-G s␣S and gpH 2 R-G s␣S . Moreover, with this receptor mutant enhanced basal GTPase activities, increased potencies of the agonists as well as increased inverse agonist efficacies of antagonists were detected, representing the hallmarks of enhanced constitutive activity compared with the wild-type proteins . The determination of AC activity in Sf9 cell membranes has previously shown to be an alternative and sensitive system to quantify differences in the constitutive activities of GPCRs (Seifert et al., 1998a) . In membranes expressing hH 2 R-C17Y-A271D-G s␣S the high basal AC activ-TABLE 2 Potencies and inverse agonist efficacies of antagonists at hH 2 R-G s␣S , gpH 2 R-G s␣S , and hH 2 R-C17Y-A271D-G s␣S in the GTPase assay Steady-state GTPase activity in Sf9 membranes expressing hH 2 R-G s␣S , gpH 2 R-G s␣S , and hH 2 R-C17Y-A271D-G s␣S was determined as described under Materials and Methods. Reaction mixtures contained Sf9 membranes expressing fusion proteins, 1 M HA as agonist and antagonists at concentrations from 1 nM to 1 mM as appropriate to generate saturated competition curves. Competition curves were analyzed by nonlinear regression. To determine the inverse agonist efficacies (Inv. Ago. Eff.), the effects of antagonists at fixed concentrations (10 M RAN, FAM, APT, and IAPT; 100 M CIM) on basal GTPase activity were assessed and referred to the stimulatory effect of 100 M HA (ϭ1.00). Data shown are the means Ϯ S.D. of three experiments performed in duplicates. K B values and inverse agonist efficacies, respectively, of antagonists at hH 2 R-G s␣S were compared with the corresponding parameters at gpH 2 R-G s␣S and hH 2 R-C17Y-A271D-G s␣S , respectively, using the t test. The control data for hH 2 R-G s␣S and gpH 2 R-G s␣S are identical with the control data for these constructs in Table 2 of Preuss et al. (2007 Basal AC activities and the effects of GTP and HA on AC activities in membranes expressing hH 2 R-C17Y-G s␣S and hH 2 R-C17Y-A271D-G s␣S were assessed and compared with the corresponding values at hH 2 R-G s␣S and gpH 2 R-G s␣S . AC activity in Sf9 membranes was determined as described under Materials and Methods. Reaction mixtures contained Sf9 membranes (20 g protein/tube) expressing fusion proteins and distilled water (basal), 10 M GTP, or 10 M GTP plus 100 M HA. Data shown are the means Ϯ S.D. of three experiments performed in triplicates. To calculate the stimulatory effect of GTP (Rel. GTP Effect), the effect of 10 M GTP was referred to the effect of 10 M GTP plus 100 M HA. The control data for hH 2 R-G s␣S and gpH 2 R-G s␣S are identical with the control data for these constructs in Table 3 of Preuss et al. (2007) . ities and the strong AC activity increases upon stimulation with GTP additionally reflect high constitutive activity compared with hH 2 R-G s␣S , gpH 2 R-G s␣S , and hH 2 R-C17Y-G s␣S .
The discovery of increased constitutive activity at hH 2 R-C17Y-A271D-G s␣S further supports the concept of an H-bond between Tyr-17 in TM1 and Asp-271 in TM7 (Kelley et al., 2001) as basis for the distinct pharmacological properties of human and guinea pig H 2 Rs. Our data suggest that this interhelical interaction stabilizes an active receptor conformation not only when agonists are bound but also when ligands are absent. However, gpH 2 R-G s␣S containing Tyr-17 and Asp-271 also was similarly constitutively active as hH 2 R-G s␣S which is presumably due to additional intramolecular interactions constraining the gpH 2 R in an inactive conformation and thereby compensating for the activating function of both residues.
Of interest, the tertiary structure of the ␣ 1b -AR contains Lys-331 in TM7 corresponding to Ala-271 in hH 2 R. Strikingly, ␣ 1b -AR mutants with Lys-331 exchanged by alanine or glutamate were more constitutively active than wild-type ␣ 1b -AR (Porter et al., 1996) , suggesting a general role of an amino acid at this position for the activation mechanism of related GPCRs.
Species Selectivity of Guanidines and N G -Acylguanidines at Wild-Type and Mutant H 2 R-G s␣S . The main intention of this study was to elucidate the impact of Cys-17/ Tyr-17 and Ala-271/Asp-271 on the species selectivity of N- [3-(1H-imidazol-4-yl) propyl]guanidines and N G -acylated imidazolypropylguanidines between hH 2 R and gpH 2 R. In our GTPase activity experiments, some of these agonists were more potent and more efficacious at hH 2 R-C17Y-A271D-G s␣S than at hH 2 R-G s␣S , and some compounds were not selective. Overall, the potencies and efficacies of the agonists were still higher at gpH 2 R-G s␣S than at hH 2 R-C17Y-A271D-G s␣S . The following conclusions can be drawn from these results.
First, both Tyr-17 and Asp-271 contribute to the enhanced potencies and efficacies of guanidines and N G -acylguanidines at the gpH 2 R. This investigation adds to a previous study at an hH 2 R-A271D-G s␣S mutant conferring high potency to guanidines without affecting the efficacies (Kelley et al., 2001 ). However, the pharmacological differences between hH 2 R-C17Y-A271D-G s␣S and gpH 2 R-G s␣S indicate that more than these two amino acids determine the species selectivity of agonists and will have to be identified in future mutagenesis studies.
Second, the concept of ligand-specific conformations in H 2 R species (Kelley et al., 2001; Kenakin, 2003; Xie et al., 2006a) is further supported. The variable side chains of the compounds distinctly interact with wild-type and mutant H 2 R-G s␣S , which is represented by compounds 8 and 9 containing a 2-thiazolyl group and being more potent at hH 2 R-C17Y-A271D-G s␣S than at hH 2 R-G s␣S in contrast to compound 10 with a cyclohexyl group being similarly potent at both proteins. The 5-methyl-1H-imidazol-4-yl group in IMP (5) presumably directly interacts with Asp-271 (Kelley et al., 2001) , yielding the high-potency increase of ϳ4-fold at hH 2 R-C17Y-A271D-G s␣S versus hH 2 R-G s␣S .
GPCRs with enhanced constitutive activity exhibit an increased affinity for agonists with the affinity increase being correlated with the efficacy of the ligand . Accordingly, the parameter of constitutive activity not only affects elevated potencies of small H 2 R agonists at hH 2 R-C17Y-A271D-G s␣S but also potency increases of the guanidines and N G -acylguanidines. Different magnitudes of constitutive activity therefore add to the complexity of the system for the analysis of species-selective ligand/GPCR interactions. Moreover, inverse agonists are less potent at constitutively active than at quiescent GPCRs (Kenakin, 2001) . Accordingly, 14 to 18 were expected to be less potent at the more constitutively active hH 2 R-C17Y-A271D-G s␣S than at hH 2 R-G s␣S . However, the potencies of inverse agonists were not decreased, and 16 and 18 were even more potent at the mutant receptor, assuming that not only guanidine-type agonists but also inverse agonists could stabilize ligand-specific conformations in H 2 R species isoforms.
Conclusions
In the present study, we demonstrate that an hH 2 R-G s␣S fusion protein with mutations of Cys-173 Tyr-17 in TM1 and Ala-2713 Asp-271 in TM7 displayed enhanced constitutive activity compared with hH 2 R-G s␣S and gpH 2 R-G s␣S . We additionally showed that an interaction between Tyr-17 and Asp-271 in gpH 2 R contributes to the species-selective action Table 3 . Data were analyzed by nonlinear regression and were best fitted to sigmoidal concentrationresponse curves. Please note the different scale of the ordinate in D. The control data for hH 2 R-G s␣S and gpH 2 R-G s␣S are identical with the control data for these constructs in Fig. 6 of Preuss et al. (2007) . -[3-(1H-imidazol-4-yl) propyl]guanidines and their N Gacylated derivatives. Distinct potencies and efficacies of agonists and inverse agonists further support the concept of ligand-specific conformations in wild-type and mutant H 2 R-G s␣S fusion proteins. A single point mutation of Cys-173 Tyr-17 was devoid of efficient GPCR-G protein coupling. By analogy, point mutations of Phe-1533 Leu-153 or Ile-4333 Val-433 in the hH 1 R (hH 1 R3gpH 1 R) resulted in functional inactivity, whereas a Phe-1533 Leu-153/Ile-4333 Val-433 double mutant was functionally active . The reasons for the annihilating effects of the single point mutations hH 1 R and hH 2 R are not known, but they illustrate the limitations of site-directed mutagenesis experiments. The characterization of closely related wild-type GPCR species isoforms is, therefore, an important alternative approach to relate distinct pharmacological properties to relatively few molecular determinants.
Point Mutations in the Human
Taken together, our mutational studies provide unique insight into the molecular mechanisms of H 2 R functions and will help us to find potent and selective agonists for the hH 2 R that may be useful as positive inotropic drugs for the treatment of severe congestive heart failure, as agents inducing cell differentiation in acute myelogenous leukemia, and as anti-inflammatory drugs.
